Actions

Test: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 12: Line 12:
<div style="width: 95%; overflow: auto; border: 1px solid navy; font-size:100%">
<div style="width: 95%; overflow: auto; border: 1px solid navy; font-size:100%">
{| class="wikitable" style="color:black; background-color:#ffffff;" cellpadding="5"
{| class="wikitable" style="color:black; background-color:#ffffff;" cellpadding="5"
!colspan="4" style = "font-size:110%; color: navy; text-align:center; background:#DEE0DE;"|'''Immunophenotype of CLL'''
!colspan="4" style = "font-size:110%; color: navy; text-align:center; background:#DEE0DE;"|'''Immunophenotype of DLBCL'''
|-
|-
!colspan="4" style = "font-size:90%; background:#DAE8F2"|Major markers useful in CLL diagnosis  
!colspan="4" style = "font-size:90%; background:#DAE8F2"|Major markers useful in CLL diagnosis  

Revision as of 13:02, 12 July 2023


DLBCL.jpg


Background to flow cytometric diagnosis

This is an uncommon diagnosis by flow cytometry as DLBCL cells generally circulate and involve bone marrow only at only a late stage in disease (ofetn when a diagnosis has already been made). However, occasionally these cases can present as a new diagnosis by blood or marrow and can be difficult as marker expression is often variable between cases.


Immunophenotype of DLBCL
Major markers useful in CLL diagnosis
Marker Freq Level Comment
CD19 -
κ/λ -
CD5 - Characteristic of CLL, usually less strong than on T cells
CD23 - Characteristic of CLL, although can rarely be weak or absent
CD79b wk Expression is expected, but characteristically weak
CD200 - Characteristically positive in CLL and negative in MCL
FMC7 May be expressed by atypical cases, generally absent
Other relevant markers
CD10 -
CD11C -
CD20 -
CD25 -
CD38 -
CD43 -
CD103 -
CD138 -


Key to table:

Key to colour code for expression frequency Click for link

Key to expression strength code and use Click for link